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Stem cell research has been developed, and today we can witness some stem cell clinical trials are on going in Indonesia. 
To meet a successful stem cell treatment, several factors need to be considered, such as cell number. Cell number has 
been reported to be crucial, and therefore optimal cell number should be achieved. Meanwhile, in some circumstances, 
cell number is not enough, therefore cell number should be enriched in an in vitro stem cell culture setting. In an in vitro 
stem cell culture, besides suitable and sterile equipment, reagents such as culture medium, serum and antibiotics are 
all important. Although all those criteria are fulfilled, somehow stem cell enrichment cannot be achieved, cell number is 
still below the target. Modification of stem cell microenvironment should then be an alternative. The addition of growth 
factors is a part of the strategies to reach a better enrichment. So that, stem cells could later be induced to proliferate at a 
higher rate. This strategy was then pursued by the scientist involved in herbal medicine. Herbal extracts were now highly 
investigated due to its potential to induce cell proliferation. Some herbal extracts inducing proliferation and differentiation 
of stem cell will be shown and described.
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Introduction
Stem cells with phenomenal ability, which can regenerate, 
proliferate and at the same time differentiate, attract the 
attention of both medical and non medical sites. People 
are amazed with the potential usage of stem cell in many 
aspects. Despite the scientific aspect, the study of stem cells 
in various other aspects is now also a topic that is often 
discussed in various meetings.1
 Generally, stem cells are divided into embryonic 
and adult stem cells. Advancement in embryonic stem cell 
methods has been widely reported, including embryonic 
stem cell identification, culture and differentiation2,3; 
Somatic  Cell  Nuclear  Transfer4,5, Altered Nuclear 
Transfer6, inner cell mass selected isolation7. However, due 
to some ethical problems, human embryonic stem  cells 
can  not  be  investigated  in  some  countries,  including 
Indonesia.8
 Meanwhile, adult stem cells are not facing such ethical 
problems.8 Moreover, adult stem cells can be found from 
variety of sources, including: umbilical cord blood, bone 
marrow, peripheral blood, fat tissue, etc.1,9 Adult stem cells 
C e l l  a n d 
B i o p h a r m a c e u t i c a l 
I n s t i t u t e
Date of submission: August 20, 2017
Accepted for publication: September 20, 2017
Corresponding Author: 
Ferry Sandra
Department of Biochemistry and Molecular Biology, Division of Oral Biology 




Print ISSN: 2527-4384, Online ISSN: 2527-3442DOI: 10.21705/mcbs.v2i1.19Molecular and Cellular Biomedical Sciences, Vol.2 No.1, March 2018, p.19-22.
are no less important than embryonic stem cells, because 
their numbers and functions are also very adequate and 
potential for the treatment of various diseases.1,9,10 Moreover, 
umbilical cord blood has shown its unique property through 
its low immunogenicity profile.11 Since the fetomaternal 
tissues of cord blood, umbilical cord matrix, and placenta 
have been demonstrated to express Oct-4, the tissue could 
be a  good  source for both embryonic and adult stem 
cells.12 Not only umbilical cord blood, fat tissue contain 
mesenchymal stem cells that have immunomodulatory 
effects.13
 The application of stem cell therapy in the medical field 
are rapidly developing. Efforts to achieve the applications 
also vary, such as the development of stem cell and its 
microenvironment isolation methods14,15, development 
of methods to increase the number of stem cells16-22, 
the development of stem cell differentiation methods23 
(including cell reprogramming)24,25, stem cell storage 
methods26,27, the development of stem cell transplantation 
methods16,28, etc. Since then, some particular stem cell types 
with their potential differentiation capacities can be isolated 
and cultured to meet the requirement of each clinical study 
to be explored.29,30
 Stem cell research has been developed and at present 
we can witness some stem cell clinical trials are on going 
in Indonesia. To meet a successful stem cell treatment, 
several factors need to be considered, such as cell number. 
Cell number has been reported to be crucial, and therefore 
optimal cell number should be achieved. Meanwhile, in 
some circumstances, cell number is not enough, so therefore 
cell number should be enriched in an in vitro stem cell 
culture setting.16,17,19-22
 In an in vitro stem cell culture, besides suitable and 
sterile equipment, reagents such as culture medium, serum 
and antibiotics are all important. Although all those criteria 
are fulfilled, somehow stem cell enrichment cannot be 
achieved, cell number is still below the target. Modification 
of stem cell microenvironment should then be an alternative. 
The addition of growth factors is a part of the strategies to 
reach a better enrichment. So that, stem cells could later 
be induced to proliferate at a higher rate. This strategy 
was  then  pursued  by  the  scientist  involved  in  herbal 
medicine.  Herbal extracts were now highly investigated due 
to its potential to induce cell proliferation.31-34 The following 
are some potential herbal extracts in inducing stem cell 
proliferation.
Tea Extract
Tea as a source of flavonoids has been shown to have strong 
reactive oxygen species (ROS) scavenging activity and 
prevent low-density lipoprotein (LDL) to oxidize. Tea extract 
consists of epigallocatechin gallate (EGCG), epicatechin 
gallate (ECG), epigallocatechin (EGC) and catechin (C).31 
EGCG was reported to induce proliferation of adipose 
tissue-derived mesenchymal stem cells (AD-MSCs). In 
addition, EGCG induces differentiation of AD-MSCs into 
endothelial progenitor cells (EPCs) as well.32 Later, it was 
found that EGCG, ECG, EGC and C of tea extract could 
induce differentiation of peripheral blood mononuclear 
cells (PB-MNCs) into peripheral blood-derived EPCs (PB-
EPCs).31 The resulted PB-EPCs were confirmed by flow 
cytometry to detect EPCs membrane markers expressions 
(CD34, CD133, VEGFR-2). Treatment of EGCG, ECG, 
EGC and C increased the percentages of all CD34, CD133, 
VEGFR-2 expressions.31 In addition, EGCG, ECG, EGC 
and C could protect PB-EPCs from oxidative damage by 
suppressing the intracellular ROS levels as well.31 Therefore 
tea flavonoids might be related to PB-EPCs production and 
protection.
Curcuma longa Extract (CLE)
CLE contains curcuminoid compounds which have high 
antioxidant activity. Some of the curcuminoid compounds 
are curcumin, demethoxy curcumin and bisdemethoxy 
curcumin, which have higher antioxidative activities 
compared with α-tocopherol. Curcumin, a pigment isolated 
from turmeric (Curcuma longa L.), has antioxidant and 
anti-inflammatory properties. Curcumin is able to prevent 
methylglyoxal-induced oxidative stress and apoptosis in 
mouse embryonic stem cells and blastocysts.32 Based on 
previous report, it is known that IC50 of CLE on 2,2-diphenyl-
1-picrylhydrazyl (DPPH) scavenging activity was 7.61 μg/
mL. The highest proliferation rates were induced by CLE at 
concentrations of 1 μg/mL. CLE stimulated differentiation 
of AD-MSCs into EPCs marked by over expression of 
CD34, CD133 and VEGFR-2.32 
Caffeic Acid
Caffeic acid, a major representative of hydroxycinnamic 
acids, is found in various green plants and is involved 
in food mainly as an ester with quinic acid, which is 
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designated as chlorogenic acid (3-0-caffeoylquinic acid). 
Caffeic acid found in natural resources, such as legumes, 
grapes and coffee. Caffeic acid has been shown to inhibit 
the differentiation of osteoclastic progenitor into osteoclast, 
known as osteoclastogenesis.35,36 The osteoclastogenesis 
induced by receptor activator nuclear factor kB ligand 
(RANKL) and tumor necrosis factor alpha (TNF-a) could 
be inhibited by caffeic acid through the NFkB underlying 
mechanism.35 Later on, it was found out that caffeic acid 
inhibited RANKL - TNF-a - TNF receptor-associated factor 
6 (TRAF6)-induced osteoclastogenesis pathway, but did not 
influence TRAF6 expression.36
Conclusion
Herbal extract has been shown to be useful in inducing 
proliferation and differentiation of stem cell/progenitor cells. 
In the same time, the extract can also inhibit differentiation 
of osteoclastic progenitor. This shows that some extracts 
have different specific role in cell differentiation. Hence, 
depending on their activities, the extract can be beneficial 
for future use in medicine. Therefore, other potential herbal 
extracts in Indonesia should be further explored.
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